In view of these, multiple targets were identified in AD such as Aβ42 peptide, acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), BACE-1, monoamine oxidase-B (MAO-B), and reactive oxygen species (ROS). This evidence concerns the gene BACE1 and Alzheimer disease.